How to buy Lexaria Bioscience Corp stock (Lexaria Bioscience Corp)

Lexaria Bioscience, a Kelowna, Canada-based company that develops drug delivery platforms, is seeking a listing on the Nasdaq. The company is currently listed on the Over-the-Counter Markets under the ticker "LXRP," as well as the Canadian Securities Exchange under the ticker symbol "LXX."

Our top picks for where to buy Lexaria Bioscience stock

Buy Lexaria Bioscience Corp stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Lexaria Bioscience Corp stock price (NASDAQ: LEXX)

Use our graph to track the performance of LEXX stocks over time.

Lexaria Bioscience Corp shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$2.23
52-week range	$1.20 - $6.85
50-day moving average more info button	$2.43
200-day moving average more info button	$3.02
Wall St. target price	$10.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.47

Is it a good time to buy Lexaria Bioscience Corp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lexaria Bioscience Corp price performance over time

Historical closes compared with the close of $2.21 from 2024-12-19

1 week (2024-12-13)	-1.34%
1 month (2024-11-21)	2.31%
3 months (2024-09-20)	-32.21%
6 months (2024-06-21)	-17.84%

1 year (2023-12-21)	64.93%
2 years (2022-12-21)	-9.80%
3 years (2021-12-21)	4.4
5 years (2019-12-20)	11.8215

Lexaria Bioscience Corp financials

Revenue TTM	$411,019
Gross profit TTM	$183,556
Return on assets TTM	-38.21%
Return on equity TTM	-70.66%
Profit margin	0%
Book value	$0.64
Market Capitalization more info button	$36.8 million

TTM: trailing 12 months

Lexaria Bioscience Corp share dividends

We're not expecting Lexaria Bioscience Corp to pay a dividend over the next 12 months.

You may also wish to consider:

• Pfizer (PFE.US) (6.64% forward annual dividend yield)

Have Lexaria Bioscience Corp's shares ever split?

Lexaria Bioscience Corp's shares were split on a 1:30 basis on 11 January 2021 . So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lexaria Bioscience Corp shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Lexaria Bioscience Corp shares which in turn could have impacted Lexaria Bioscience Corp's share price.

Lexaria Bioscience Corp share price volatility

Over the last 12 months, Lexaria Bioscience Corp's shares have ranged in value from as little as $1.2 up to $6.85. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lexaria Bioscience Corp's is 1.056. This would suggest that Lexaria Bioscience Corp's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

To put Lexaria Bioscience Corp's beta into context you can compare it against those of similar companies.

• Pfizer (PFE.US): 0.615
• Moderna (MRNA.US): 1.69
• BioNTech (BNTX.US): 0.259

Lexaria Bioscience Corp overview

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. Its DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, creams, lotions, and skin patches; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp.

Frequently asked questions

null
What percentage of Lexaria Bioscience Corp is owned by insiders or institutions?
Currently 7.03% of Lexaria Bioscience Corp shares are held by insiders and 6.08% by institutions. How many people work for Lexaria Bioscience Corp?
Latest data suggests 5 work at Lexaria Bioscience Corp. When does the fiscal year end for Lexaria Bioscience Corp?
Lexaria Bioscience Corp's fiscal year ends in August. Where is Lexaria Bioscience Corp based?
Lexaria Bioscience Corp's address is: 740 McCurdy Road, Kelowna, BC, Canada, V1X 2P7 What is Lexaria Bioscience Corp's ISIN number?
Lexaria Bioscience Corp's international securities identification number is: US52886N4060